Uniklinik Köln

Futó vizsgálatok

• Még nem toboroz

  Safety and Efficacy of Ruxolitinib in Patients With HNSCC and High NLR Treated With Pembrolizumab - The Phase 2 InflammaSTOP Trial

  NCT07840456· 2. fázis· Forrás

• Toboroz

  PULSed Field Ablation for Atrial Fibrillation Using a Balloon for Early Intervention - Study

  NCT07621003· Forrás

• Toboroz

  Impella Pump Return Study to Analyze Deposits and Biomaterial in Used Pumps

  NCT06765226· Forrás

• Toboroz

  FMRI-neurofeedback in Parkinson's Disease

  NCT06582355· Forrás

• Fut, nem toboroz

  A Study of Obexelimab in Patients With Systemic Lupus Erythematosus

  NCT06559163· 2. fázis· Forrás

• Toboroz

  Radiofrequency (RF) Ablation Prospective Outcomes Study for Central Nervous System - RAPID for CNS

  NCT06553625· Forrás

• Meghívásos bevonás

  An Extension Study to Assess Long-Term Safety of Eplontersen in Adults With Transthyretin-Mediated Amyloid Cardiomyopathy (ATTR-CM)

  NCT05667493· 3. fázis· Forrás

• Fut, nem toboroz

  Prognostic Role of Circulating Tumor DNA in Resectable Pancreatic Cancer

  NCT04246203· Forrás

• Fut, nem toboroz

  Long-Term Observational Study on Effectiveness and Safety of Lecigon in Patients With Advanced Parkinson's Disease

  NCT05043103· Forrás

• Fut, nem toboroz

  Treatment With Bempedoic Acid and/or Its Fixed-dose Combination With Ezetimibe in Primary Hypercholesterolemia or Mixed Dyslipidemia

  NCT04579367· Forrás

• Fut, nem toboroz

  MINIject Global Long-Term Follow-up Study

  NCT04524416· Forrás

• Toboroz

  Deep Brain Stimulation (DBS) Retrospective Outcomes Study

  NCT03664609· Forrás

• Meghívásos bevonás

  Adoptive Cell Therapy Long-term Follow-up (LTFU) Study

  NCT03391778· 1. fázis· Forrás

Egyszerre toboroz

Hány vizsgálat toboroz itt egyszerre ugyanarra az indikációra. Darabszám, nem értékelés.

• Parkinson-kór3 toboroz
• Amiloidózis1 toboroz
• Fej-nyaki daganatok1 toboroz
• Gyermekkori daganatok1 toboroz
• Pitvarfibrilláció1 toboroz
• Szívelégtelenség1 toboroz

Kutatók

Ide még nem kötődik kutató.

Lezárt vizsgálatok

• Toboroz

  A Study Evaluating the Safety, Efficacy, and Pharmacokinetics of Mosunetuzumab and a Combined Regimen of Mosunetuzumab and Venetoclax in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia

  NCT05091424· 1. fázis· Forrás

• Lezárult

  A Study of Nipocalimab in Adults With Primary Sjogren's Syndrome (pSS)

  NCT04968912· 2. fázis· Forrás

• Lezárult

  Safety and Tolerance of Epigenetic and Immunomodulating Drugs Combined With Chemotherapeutics in Patients Suffering From Advanced Pancreatic Cancer

  NCT04257448· 1/2. fázis· Forrás

• Lezárult

  CARDIO-TTRansform: A Study to Evaluate the Efficacy and Safety of Eplontersen (Formerly Known as ION-682884, IONIS-TTR-LRx and AKCEA-TTR-LRx) in Participants With Transthyretin-Mediated Amyloid Cardiomyopathy (ATTR CM)

  NCT04136171· 3. fázis· Forrás

• Lezárult

  A Safety Extension Study of Ontamalimab in Participants With Moderate to Severe Ulcerative Colitis or Crohn's Disease (AIDA)

  NCT03283085· 3. fázis· Forrás

• Toboroz

  Registry of Deep Brain Stimulation With the VERCISE™ System: Vercise DBS Registry

  NCT02071134· Forrás

• Lezárult

  A Phase 3 Open Label Randomized Study to Compare the Efficacy and Safety of Rituximab Plus Lenalidomide (CC-5013) Versus Rituximab Plus Chemotherapy Followed by Rituximab in Subjects With Previously Untreated Follicular Lymphoma

  NCT01650701· 3. fázis· Forrás